Topotecan Completed Phase 1 Trials for Cancer of the Ovary / Lung Cancers / Cervical Cancers / Endometrial Cancers Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00287963Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer
NCT00315861Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies
NCT00322751Concurrent Radiotherapy With Weekly Topotecan for Primary Treatment of Inoperable Localized Non-small Cell Lung Cancer
NCT00002537Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung Cancer
NCT00287911Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer
NCT00320983Study of Adjuvant Topotecan and Cisplatin With Concurrent Radiation Therapy for Advanced Cervical Cancer
NCT00703807Study of the Weekly Oral RAD001 in Combination With Oral Topotecan in Patients With Advanced or Recurrent Endometrial Cancers
NCT00250094Clinical Benefit of Topoisomerase Downregulation